Detalhe da pesquisa
1.
Efficacy of venetoclax plus rituximab for relapsed CLL: 5-year follow-up of continuous or limited- duration therapy.
Blood
; 138(10): 836-846, 2021 09 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34115103
2.
Targeting BCL-2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma.
Am J Hematol
; 96(4): 418-427, 2021 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33368455
3.
Posterior brain sensorimotor recruitment for inhibition of delayed responses in children.
Exp Brain Res
; 239(11): 3221-3242, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-34448892
4.
Hypoxia promotes tau hyperphosphorylation with associated neuropathology in vascular dysfunction.
Neurobiol Dis
; 126: 124-136, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30010004
5.
Identification of recurrent genomic alterations in the apoptotic machinery in chronic lymphocytic leukemia patients treated with venetoclax monotherapy.
Am J Hematol
; 97(2): E47-E51, 2022 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34779028
6.
Impact of venetoclax monotherapy on the quality of life of patients with relapsed or refractory chronic lymphocytic leukemia: results from the phase 3b VENICE II trial.
Leuk Lymphoma
; 63(2): 304-314, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34632935
7.
Safety and efficacy of navitoclax, a BCL-2 and BCL-XL inhibitor, in patients with relapsed or refractory lymphoid malignancies: results from a phase 2a study.
Leuk Lymphoma
; 62(4): 810-818, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33236943
8.
Long-term Follow-up of Patients with Relapsed or Refractory Non-Hodgkin Lymphoma Treated with Venetoclax in a Phase I, First-in-Human Study.
Clin Cancer Res
; 27(17): 4690-4695, 2021 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34083230
9.
Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.
Cancer Discov
; 11(6): 1440-1453, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33593877
10.
Biomarkers identify the Binswanger type of vascular cognitive impairment.
J Cereb Blood Flow Metab
; 39(8): 1602-1612, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29513153
11.
MMP-9 inhibitors impair learning in spontaneously hypertensive rats.
PLoS One
; 13(12): e0208357, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30533010